Are you Dr. Rainey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
NE Pacific St
# 1959
Seattle, WA 98195Phone+1 206-598-6131Fax+1 206-598-6189
Summary
- Dr. Petrie Rainey, MD is a board certified pathologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, Connecticut, and California. He is affiliated with UW Medicine/University of Washington Medical Center and is a Professor at University of Washington School of Medicine.
Education & Training
University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1983 - 1985- University of California (San Francisco) School of MedicineResidency, Clinical Pharmacology, 1981 - 1983
- University of California (San Francisco)Residency, Pediatrics, 1980 - 1981
University of North Carolina at Chapel Hill School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1981 - Present
WA State Medical License 2000 - 2026
CT State Medical License 1985 - 2000- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 58 citationsModified directly observed therapy (MDOT) for injection drug users with HIV disease.Elinore F. McCance-Katz M.D., Marc N. Gourevitch, Julia Arnsten, P A Julie Sarlo, Petrie Rainey
The American Journal on Addictions. 2002-10-01 - 32 citationsThe PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux.Heather L. Callahan, William L. Roberts, Petrie M. Rainey, Stephen M. Beverley
Molecular and Biochemical Parasitology. 1994-11-01 - 39 citationsHIV drug interactions: the good, the bad, and the other.Petrie M. Rainey
Therapeutic Drug Monitoring. 2002-02-01
Grant Support
- Mechanisms Of Antileishmanial DrugsNational Institute Of Allergy And Infectious Diseases1989–1991
